|
2
|
29
|
29ckA |
Solution structure of glucagon peptide at ph 2.5 |
|
0
|
29
|
28uxA |
Solution structure of glucagon peptide in dmso |
|
7
|
30
|
9s2qB |
Nh-triazol-modified insulin |
|
5
|
21
|
9s2qA |
Nh-triazol-modified insulin |
|
0
|
29
|
28tgA |
Solution structure of glucagon peptide in water |
|
4
|
21
|
9zdlA |
A6-a11 diselenide glargine insulin |
|
5
|
32
|
9zdlB |
A6-a11 diselenide glargine insulin |
|
8
|
29
|
9utkB |
Monoclinic crystal structure of acid-stable protracted insulin (293 k) |
|
4
|
21
|
9utkA |
Monoclinic crystal structure of acid-stable protracted insulin (293 k) |
|
8
|
29
|
9utjB |
Monoclinic crystal structure of acid-stable protracted insulin |
|
4
|
21
|
9utjA |
Monoclinic crystal structure of acid-stable protracted insulin |
|
5
|
21
|
9qldA |
Rhombohedral crystalline form of human insulin complexed with m-nitrophenol |
|
8
|
28
|
9qldB |
Rhombohedral crystalline form of human insulin complexed with m-nitrophenol |
|
8
|
27
|
9ibbB |
Rhombohedral crystalline form of human insulin complexed with m-cresol |
|
4
|
21
|
9ibbA |
Rhombohedral crystalline form of human insulin complexed with m-cresol |
|
82
|
264
|
9un4A |
Crystal structure of juvenile hormone acid methyltransferase castaneum jhamt3 from tribolium castaneum |
|
98
|
267
|
9uj9A |
Crystal structure of sme-1 e166a in complex with cefotaxime |
|
8
|
29
|
25hlB |
Sfx crystal structure of insulin detemir |
|
9
|
29
|
25hfB |
Sfx crystal structure of insulin aspart |
|
5
|
21
|
25hfA |
Sfx crystal structure of insulin aspart |
|
5
|
21
|
25hlA |
Sfx crystal structure of insulin detemir |
|
6
|
32
|
9tb1B |
Crystal structure of an acylated glp-1/gip analogue peptide |
|
35
|
119
|
9yxdK |
Crystal structure of recombinant human follicle stimulating hormone in complex with an anti-fsh alpha fab |
|
8
|
87
|
9yxdA |
Crystal structure of recombinant human follicle stimulating hormone in complex with an anti-fsh alpha fab |
|
49
|
218
|
9yxdC |
Crystal structure of recombinant human follicle stimulating hormone in complex with an anti-fsh alpha fab |
|
53
|
216
|
9yxdD |
Crystal structure of recombinant human follicle stimulating hormone in complex with an anti-fsh alpha fab |
|
11
|
106
|
9yxdB |
Crystal structure of recombinant human follicle stimulating hormone in complex with an anti-fsh alpha fab |
|
125
|
428
|
9utdA |
Influx carrier substrate bound form |
|
135
|
426
|
9uteA |
Influx carrier apo form |
|
5
|
21
|
9r49A |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (25 ms soaking) |
|
4
|
21
|
9r4bA |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (250 ms soaking) |
|
5
|
21
|
9r4aA |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (50 ms soaking) |
|
6
|
30
|
9r4cB |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (500 ms soaking) |
|
6
|
30
|
9r49B |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (25 ms soaking) |
|
6
|
30
|
9r48B |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 9.0 (apo state) |
|
6
|
30
|
9r4aB |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (50 ms soaking) |
|
4
|
21
|
9r4eA |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (5 s soaking) |
|
4
|
21
|
9r4cA |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (500 ms soaking) |
|
6
|
21
|
9r48A |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 9.0 (apo state) |
|
6
|
30
|
9r4eB |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (5 s soaking) |
|
7
|
30
|
9r4bB |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (250 ms soaking) |
|
7
|
29
|
8rrpB |
Insulin icodec - a14e b16h b25h b29ne-c20 diacid-lgglu-2xado desb30 human insulin |
|
5
|
21
|
8rrpA |
Insulin icodec - a14e b16h b25h b29ne-c20 diacid-lgglu-2xado desb30 human insulin |
|
8
|
30
|
8wu0B |
Crystal structure of lisargine |
|
5
|
21
|
8wu0A |
Crystal structure of lisargine |
|
5
|
21
|
9m4yA |
Cubic insulin crystal, esrapid, at ph 3 |
|
7
|
29
|
9m4zB |
Cubic insulin crystal, esrapid, at ph 4 |
|
5
|
21
|
9lvxA |
Di-hexamer form of insulin detemir at ambient temperature |
|
4
|
21
|
9lveA |
Temperature induces a shift from the dihexamer to the hexamer form of insulin (300k) |
|
9
|
29
|
9lveB |
Temperature induces a shift from the dihexamer to the hexamer form of insulin (300k) |
